Global Minimal Residual Disease (MRD) Testing Market Size, Share, and COVID-19 Impact Analysis, By Technology (Flow-cytometry, Polymerase Chain Reaction {PCR}, Next Generation Sequencing {NGS}), By Test Type (DNA-based Test, RNA-based Test, Immunological Test), By Application (Lymphoma, Leukemia, Solid Tumors), By End Use (Hospitals, Specialty Clinics, Diagnostic Laboratories, Research & Academic Institutes), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 – 2032
Industry: Healthcare
Need help to buy this report?
Inquiry Before Buy